Gold and silver nanoparticles in Alzheimer's and Parkinson's diagnostics and treatments
Ibrain · 2023-09 · 9 (3) · 298-315
DOI: 10.1002/ibra.12126 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ibrain, online erschienen am 14.08.2023. Verfasst von Edoardo Scarpa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences (DISFARM) University of Milan Milan Italy. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Neurodegenerative diseases (NDs) impose substantial medical and public health burdens on people worldwide and represent one of the major threats to human health. The prevalence of these age‐dependent disorders is dramatically increasing over time, a process intrinsically related to a constantly rising percentage of the elderly population in recent years. Among all the NDs, Alzheimer's and Parkinson's are considered the most debilitating as they cause memory and cognitive loss, as well as severely affecting basic physiological conditions such as the ability to move, speak, and breathe. There is an extreme need for new and more effective therapies to counteract these devastating diseases, as the available treatments are only able to slow down the pathogenic process without really stopping or resolving it. This review aims to elucidate the current nanotechnology‐based tools representing a future hope for NDs treatment. Noble metal nano‐systems, that is, gold and silver nanoparticles (NPs), have indeed unique physicochemical characteristics enabling them to deliver any pharmacological treatment in a more effective way within the central nervous system. This can potentially make NPs a new hope for reversing the actual therapeutic strategy based on slowing down an irreversible process into a more effective and permanent treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences (DISFARM) University of Milan Milan Italy.
- Infection Dynamics Laboratory-National Institute of Molecular Genetics (INGM) Milan Italy.
- Department of Mathematics and Physics "Ennio De Giorgi" University of Salento Lecce Italy.
- National Research Council of Italy (CNR)-Institute for Microelectronics and Microsystems (IMM) Lecce Italy.
ORCID-Profile: Valeria De Matteis
Zitieren
APA
Scarpa, E., Cascione, M., Griego, A., Pellegrino, P., Moschetti, G., & De Matteis, V. (2023). Gold and silver nanoparticles in Alzheimer's and Parkinson's diagnostics and treatments. Ibrain, 9(3), 298-315. https://doi.org/10.1002/ibra.12126
Vancouver
Scarpa E, Cascione M, Griego A, Pellegrino P, Moschetti G, De Matteis V. Gold and silver nanoparticles in Alzheimer's and Parkinson's diagnostics and treatments. Ibrain. 2023;9(3):298-315. doi:10.1002/ibra.12126
BibTeX
@article{Scarpa2023,
author = {Scarpa, Edoardo and Cascione, Mariafrancesca and Griego, Anna and Pellegrino, Paolo and Moschetti, Giorgia and De Matteis, Valeria},
title = {Gold and silver nanoparticles in Alzheimer's and Parkinson's diagnostics and treatments},
journal = {Ibrain},
year = {2023},
volume = {9},
number = {3},
pages = {298--315},
doi = {10.1002/ibra.12126}
}
EUVIMED